CN Patent

CN102091079A — 用于透皮给药的方法和组合物

Assigned to Acrux DDS Pty Ltd · Expires 2011-06-15 · 15y expired

What this patent protects

本发明涉及用于透皮给药的方法和组合物，所述组合物包含至少一种生理活性剂(例如丁螺环酮或芬太尼或诸如睾酮等雄激素)、至少一种挥发性溶剂(例如异丙醇或乙醇)和至少一种粘度调节剂(例如PVP)，优选还含有渗透增强剂(如水杨酸辛酯)。所述组合物优选施用于腋窝。

USPTO Abstract

本发明涉及用于透皮给药的方法和组合物，所述组合物包含至少一种生理活性剂(例如丁螺环酮或芬太尼或诸如睾酮等雄激素)、至少一种挥发性溶剂(例如异丙醇或乙醇)和至少一种粘度调节剂(例如PVP)，优选还含有渗透增强剂(如水杨酸辛酯)。所述组合物优选施用于腋窝。

Drugs covered by this patent

Patent Metadata

Patent number
CN102091079A
Jurisdiction
CN
Classification
—
Expires
2011-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Acrux DDS Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.